IBRX Return on Tangible Equity | IMMUNITYBIO, INC.

IMMUNITYBIO, INC. (IBRX) Return on Tangible Equity

2026-06-30: Return Tang Equity 93.67%.
2026-03-31: Return Tang Equity 96.79%.
2025-12-31: Return Tang Equity 68.32%.
2025-09-30: Return Tang Equity 64.71%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	93.67%
2026-03-31	96.79%
2025-12-31	68.32%
2025-09-30	64.71%
2025-06-30	62.73%
2025-03-31	67.47%
2024-12-31	81.97%
2024-09-30	77.23%
2024-06-30	83.71%
2024-03-31	84.87%
2023-12-31	96.63%
2023-09-30	106.81%
2023-06-30	71.76%
2023-03-31	78.61%
2022-12-31	89.40%
2022-09-30	93.35%
2022-06-30	89.34%
2022-03-31	109.78%
2021-12-31	142.38%
2021-09-30	165.13%
2021-06-30	182.34%
2021-03-31	136.95%
2020-12-31	174.55%
2020-09-30	-185.18%
2020-06-30	-130.38%
2020-03-31	-185.65%
2019-12-31	-139.15%
2019-09-30	-52.45%
2019-06-30	-52.47%
2019-03-31	-53.95%
2018-12-31	-69.37%
2018-09-30	-66.78%
2018-06-30	-59.49%
2018-03-31	-51.50%
2017-12-31	-45.58%
2017-09-30	-41.74%
2017-06-30	-42.38%
2017-03-31	-42.29%
2016-12-31	-42.22%
2016-09-30	-40.64%
2016-06-30	-43.06%
2016-03-31	-69.60%
2015-12-31	-67.93%
2015-09-30	-58.64%
2015-06-30	-132.31%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	68.32%
2024-12-31	81.97%
2023-12-31	96.63%
2022-12-31	89.40%
2021-12-31	142.38%
2020-12-31	174.55%
2019-12-31	-139.15%
2018-12-31	-69.37%
2017-12-31	-45.58%
2016-12-31	-42.22%
2015-12-31	-67.93%
2014-12-31	-10.74%
2013-12-31	54.51%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
Scholar Rock Holding Corp (SRRK)	United States	$5.920B	-16.37
CRISPR Therapeutics AG (CRSP)		$5.390B	-11.68